1268267-77-1

Basic information

• Product Name: 2-isopentylbenzaldehyde
• Synonyms: 2-isopentylbenzaldehyde
• CAS NO: 1268267-77-1
• Molecular Weight: 162.232
• Mol File: 1268267-77-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-isopentylbenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-isopentylbenzaldehyde(1268267-77-1)
• EPA Substance Registry System: 2-isopentylbenzaldehyde(1268267-77-1)

Safety Data

• Hazardous Substances Data: 1268267-77-1(Hazardous Substances Data)

Upstream product

• 84110-40-7 Dihydroxy-isobutyl-boran 
• 6630-33-7 ortho-bromobenzaldehyde 
• 89-71-4 2-Methyl-benzoic acid methyl ester 
• 89-95-2 2-methyl-benzyl alcohol 
• 40150-98-9 4-(2-methyl-1-propyl)benzaldehyde 

Downstream Products

• 1321200-11-6 2-(2-isobutylphenyl)acetaldehyde 
• 1321200-15-0 3-(1-hydroxy-2-(2-isobutylphenyl)ethyl)-3-methyldihydrofuran-2(3H)-one 
• 1321200-20-7 (E)-3-(2-isobutylstyryl)-3-methyldihydrofuran-2(3H)-one 
• 1321200-25-2 3-(2-(2-isobutylphenyl)-2-(triethylsilylperoxy)ethyl)-3-methyldihydrofuran-2(3H)-one 
• 1350538-95-2 C₁₃H₁₈O 
• 200631-40-9 3,3-dimethyl-2-tosyl-1,2,3,4-tetrahydroisoquinoline 

Relevant articles and documents

Synthesis and antiplasmodial activity of bicyclic dioxanes as simplified dihydroplakortin analogues

Here we report the synthesis and evaluation of antiplasmodial activity of a novel series of bicyclic peroxides inspired by the marine natural compound dihydroplakortin. We developed a synthetic strategy leading to the dihydroplakortin-related peroxides in only a few steps. The in vitro antiplasmodial potency of the peroxides was similar to, or greater than, that of the reference natural compound, and structure-activity relationship studies revealed several key structural requirements for activity and potency.

Substituted pyrimidine compositions and methods of use

Substituted pyrimidines that have the general structure: in which the symbol R1represents a C1-C6alkyl, C1-C6alkoxy or halogen atom; R2represents a phenyl group, substituted phenyl group, benzyl moiety, substituted benzyl moiety, C3-C7cycloalkyl, or substituted C3-C7cycloalkyl; R3represents a hydrogen or C1-C6alkyl group, R4represents —H, —OH, —N3or —NHCOCH3; and R5represents H are provided. These compounds have activity as inhibitors of phospholipase A2, and are useful in treating disorders mediated by phospholipase A2.